- Home
- MCBS vs PRME Comparison
MCBS vs PRME Comparison
Compare MCBS & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCBS | PRME |
|---|---|---|
| Founded | 2006 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 679.1M | 601.1M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MCBS | PRME |
|---|---|---|
| Price | $28.36 | $4.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $31.00 | $9.31 |
| AVG Volume (30 Days) | 51.9K | ★ 3.7M |
| Earning Date | 01-20-2026 | 11-07-2025 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | ★ 11.15 | N/A |
| EPS | ★ 2.59 | N/A |
| Revenue | ★ $147,349,000.00 | $5,977,000.00 |
| Revenue This Year | $13.89 | $111.80 |
| Revenue Next Year | $33.10 | N/A |
| P/E Ratio | $10.96 | ★ N/A |
| Revenue Growth | 8.69 | ★ 647.13 |
| 52 Week Low | $24.24 | $1.11 |
| 52 Week High | $35.45 | $6.94 |
Technical Indicators
Market Signals| Indicator | MCBS | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 71.29 | 52.01 |
| Support Level | $27.04 | $3.95 |
| Resistance Level | $27.48 | $4.42 |
| Average True Range (ATR) | 0.60 | 0.30 |
| MACD | 0.26 | 0.12 |
| Stochastic Oscillator | 98.38 | 76.72 |
Price Performance
Historical ComparisonAbout MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.